Lumen Bioscience
Seattle, WA, United Stateslumen.bioFrom their website, Nov 2026
- GMP
Work here? Claim this listing
About
Lumen Bioscience develops and manufactures oral biologic drugs using engineered spirulina as the production platform. The company works on therapeutic proteins for human and animal health, with a focus on diseases such as C. difficile and inflammatory bowel disease. It is based in Seattle, Washington.
Services
Hit-to-lead discovery
Executes early discovery work to identify and optimize lead biologic candidates.
Protein engineering and optimization
Designs and optimizes therapeutic proteins using in silico and protein engineering approaches.
Strain engineering
Engineers spirulina strains to express therapeutic molecules in the chromosome.
Antibody selection and optimization
Provides on-premises antibody selection and optimization capabilities.
GMP drug substance manufacturing
Produces GMP drug substance in a dedicated cGMP facility.
Clinical development
Supports clinical development with a full-time clinical operations team.
Global regulatory affairs
Handles regulatory affairs activities for development programs.
Yield optimization
Uses AI and machine learning to optimize production yield.
Capabilities
- Assays and studies
- Antibodies
- Scale and capacity
- Capacity for 15+ kilograms of GMP drug substance per week
- Therapeutic areas
- C. difficile
- Inflammatory bowel disease
- Crohn's disease
- Ulcerative colitis
- Human health
- Animal health
Instruments and platforms
- AI/machine learning–enabled yield optimization
Modalities and species
- Modalities
- Antibody
- Species and models
- Spirulina
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: production facility
Details
- Type
- CRDMO
- Founded
- 2017
- Team
- 100+ FTEs
- Office
- Bioengineering 03 Step 3 : Production The production system requires only wat
- Serves
- Global
Public records
- Wikidata
- Q135502512 source